Borusiak, Peter https://orcid.org/0000-0002-9075-2358
Mazheika, Yuliya
Bauer, Susanne
Haberlandt, Edda
Krois, Ilona
Fricke, Christian
Simon, Liane
Beschoner, Petra
Jerg-Bretzke, Lucia
Geiser, Franziska
Hiebel, Nina
Weidner, Kerstin
Albus, Christian
Morawa, Eva
Erim, Yesim
Funding for this research was provided by:
german federal ministry of education and research (01KX2021)
wagener-foundation for social pediatrics
Private Universität Witten/Herdecke gGmbH
Article History
Received: 18 August 2021
Accepted: 31 March 2022
First Online: 8 April 2022
Declarations
:
: The authors respected and abided by the legal version of the Declaration of Helsinki, published by the World Medical Association (WMA), and the University of Erlangen ethics committee (reference number: 133_20 B) approved the study. The study fully respected German and Austrian data protection regulations. All information was gathered anonymously and handled confidentially. Online informed consent was obtained from all participants included in the study.
: Not applicable.
: P.Bo. received support in the last five years from, has served as a speaker for and participated in investigations of InfectoPharm (Germany) and Central Krankenversicherung (Germany). He received grants from the Else Kröner-Fresenius Foundation, Witten/Herdecke University, Märtens-Foundation and Bundeszentrale für gesundheitliche Aufklärung (all Germany).C.A. has received speakers’ honoraria from Bayer Vital, Daichi Sankyo, UCB, Boehringer Ingelheim, Berlin Chemie, MSD Sharp & Dohme, the German Cardiac Society, and the German Diabetes Society during the last five years. He received authors’ honoraria from Schattauer-Verlag, Elsevier and DÄV, and scientific funding from the BMBF and DFG.Y.M., S.B., E.H., I.K., C.F., L.S., P.Be., L.J.-B., F.G., N.H., K.W., E.M. and Y.E. have no conflicts of interest or financial ties to disclose.